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Efficacy of albendazole against the whipworm Trichuris 
trichiura - a randomised, controlled trial 
V J Adams, C J Lombard, M A Dhansay, M B Markus, J E Fincham 
Objectives and design. To test the efficacy of albendazole 
against the whipworm Trichuris trichiura for school-based 
deworming in the south-western Cape, South Africa. 
Children infected with Trichuris were randomised to 3 doses 
of albendazole (400; 800 or 1 200 mg), each repeated 4 times. 
The boy I girl ratio was 1. A group not infected With worms 
was treated with placebo, creating a negative control. 
Subjects and setting. Pupils at a primary school serving a wine-
producing area approximately 90 km east of Cape Town. 
Outcome measures. Trichuris cure rates and reduction in the 
number of eggs/gin faeces, as well as the infection dynamics 
of Trichuris and Ascaris during treatment with placebo. 
Results. Albendazole treatment was associated with Trichuris 
Complications of helminthic infections in children and adults, 
such as intestinal and duct obstruction by Ascaris that requires 
surgery, are serious, costly, predictable and preventable. 1 ' A 
much bigger problem is the enormous burden of subclinical 
morbidity impeding the physical and mental development of 
millions of children, and the health of women. That it can be 
solved countrywide, has been demonstrated in Japan and 
Korea.' In May 2001, the World Health Assembly (WHA) urged 
member states, including South Africa, to implement control of 
soil-transmitted helminths and schistosomiasis by means of 
holistic public health measures.' 
One of the targets is synchronised, school-based deworming 
that reaches 75- 100% of school-aged children by the year 2010, 
to be implemented mainly by teachers. This is the quickest way 
to help those who need it most, in a cost-effective way because 
the price of generic anthelmintics has plummeted.'·'·' Market 
research shows that in 2003, albendazoleand mebendazole 
purchased in Europe or Asia could be delivered to schools in 
Cape Town for about 20% of the government's tender prices for 
equivalent South African generics. 
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cure rates of 23% (400 mg), 56% (800 mg) and 67% (1 200 mg) 
after the final treatment. The corresponding reductions in the 
number of eggs/g of faeces were 96.8%, 99.3% and 99.7%. 
Environmental pollution by human faeces was confirmed 
because worm egg-negative children in the placebo group 
became egg-positive while the study was in progress. 
Conclusion. The 400 mg stat dose had a low Trichuris cure rate. 
To repeat the dose on 2 or 3 days would increase cost, reduce 
compliance and complicate management. Albendazole cannot 
be used in deworming programmes in South Africa because it 
is a Schedule 4 prescription medicine. De-scheduling is 
needed urgently, particularly because of high efficacy against 
hookworm in KwaZulu-Natal and neighbouring countries. 
S Afr Med J 2004; 94: 972-976. 
In line with the WHA resolution, a school-based deworming, 
education and sanitation programme has started to develop in 
Cape Town. Communities living in poverty have priority 
because high rates of infestation with Trichuris and Ascaris have 
been detected, especially in children.'·9 In a pilot phase, 
teachers at 12 schools in Khayelitsha have dewormed the 
children twice a year since 1998, with minimal assistance. From 
January to August 2004 alone, deworming spread to 89 
primary schools attended by close to 70 000 children. The 
overall cumulative total treatments at schools is approaching 
200 000 doses of mebendazole, which can be used without a 
prescription (Schedule 1). No adverse effects of deworming 
have been reported. 
Progress of this kind emphasises the importance of using 
effective anthelmintics under prevailing ecological and 
demographic conditions. Single-dose treatments are optimal in 
terms of management and cost, with albendazole 400 mg 
tablets being one option.'-14 However, Trichuris is relatively 
refractory to this kind of treatment, as has been shown locally/"11 
and albendazole should only be used under prescription 
(Schedule 4).14 A meta-analysis of 17 trials that reported on 
single-dose treatment with 400 mg of albendazole in tropical 
countries, found a median Trichuris cure rate of 44% and a 
range of 0 - 90.5%.15 In the context of school-based deworming 
in the winter-rainfall area of the south-western Cape, where 
few data on the efficacy of albendazole have been available, a 
study was undertaken to determine the suitability of this 
anthelmintic for treatment of trichuriasis. 
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Methods 
Ethics and informed consent 
The research project was approved by the Ethics Committee of 
the Medical Research Council of South Africa, subject to a 
directive that placebo must not be given to children known to 
have worms. Researchers explained to parents, guardians and 
teachers how control of worm infestation could help to 
improve the health, nourishment, development and education 
of their children. Frank discussion took place and questions 
were answered. Parents or guardians gave consent for children 
to take part in the research and signed combined information 
and consent forms that are filed at the Medical Research 
Council. There was consensus that after the study had been 
carried out, all the children in the school should be dewormed. 
This was implemented.15 
Setting, location and eligibility 
In order to have 100% prevalence in treated groups, pupils at a 
primary school serving a village 90 km east of Cape Town were 
eligible to receive albendazole if they were infested by 
Trichuris. Children not infected by any species of helminth were 
suitable for the placebo group. Climatic features that could 
influence the epidemiology included winter rainfall that 
averages 488 mm/annum (range 37.2-814.5 mm/annum), 
mild to cold winter temperatures and hot, dry summers. 
Parents often worked in vineyards in the vicinity, and human 
population density in the area is low. 
Interventions 
To obtain treatment groups for the randomised controlled trial, 
a baseline survey was undertaken. Faecal samples from 462 
children, ranging in age from 6 to 16 years (mean 10 years), 
were screened by microscopy, using standard methods. 
Helminth eggs were counted and expressed quantitatively as 
eggs/g of faeces. Seventy-seven per cent of the children had 
worm eggs in their stools: Trichuris 69%, Ascaris 34% and dual 
infections 26%. Gender did not influence the prevalence or 
intensity of worm infestation. Chronic prescription medication 
and/ or clinically evident illness were exclusion criteria. 
For the randomised controlled trial, treatment with 
albendazole (Zentel) was by means of 400 mg tablets. Each 
tablet was in a blister pack. Albendazole doses of 800 mg and 
1 200 mg were obtained by repeating treatment on 2 or 3 
successive days, which is the prescribed procedure for 
children." Placebo tablets matched the albendazole tablets in 
appearance, as did the blister packs, and were from the same 
source. To standardise the procedure, all treatments comprised 
1 tablet a day for 3 days (Table I). Thus, children in the 400 mg 
albendazole group took 1 albendazole plus 2 placebo tablets; 
those in the 800 mg albendazole group took 2 albendazole 
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tablets and 1 placebo tablet; those in the 1 200 mg group took 3 
albendazole tablets; and those in the placebo group took 3 
placebo tablets. Children chewed the tablets before swallowing 
them with water, while being observed by a researcher and a 
teacher. Treatments were carried out during the course of a 
normal school day and were repeated 4 times at intervals of 
approximately 4 months. 
Hypothesis and outcome measures 
We hypothesised that control of trichuriasis as a public health 
measure might necessitate a dose of albendazole higher than 
400 mg stat if treatment is to be at intervals of about 4 months. 
Outcome measures were cure rate and reduction in the number 
of Trichuris eggs in faeces, i.e. the egg-reduction rate.16 Cure 
rate reflects the percentage of egg-positive individuals who 
became negative after each treatment. Egg-reduction rate was 
evaluated in terms of geometric mean (GM) egg counts because 
this is a valid method to normalise skewed data such as the 
number of Trichuris eggs/ g of stool. The GM after deworming 
was expressed as a percentage of the GM before deworming. 
Excretion of fewer eggs is a measure of the success of control in 
relation to the number of eggs available for perpetuation of 
infection.16 The 4 cycles of treatment and repeated outcome 
measurements strengthened the results. The incidence of 
infection with Trichuris and Ascaris in the group treated with 
placebo was an additional outcome measure. 
Power calculations, randomisation and blinding 
Calculations indicated that 50 children (25 girls and 25 boys) 
per treatment group should be sufficient to evaluate cure rates 
with 80% power. The calculations were based on projected cure 
rates of 25%, 35% and 50% for the 400, 800 and 1 200 mg doses 
of albendazole, respectively. On this basis, 150 children (75 
boys and 75 girls) were sufficient to form 3 treatment groups. 
The gender means for the number of Trichuris eggs in faeces 
were 2 569 eggs/ g of faeces (range 320- 32 760) for the girls 
and 1 524 eggs/g of faeces (range 350-8 200) for the boys. 
Each girl or boy was identified by a unique numerical code. A 
statistician operating independently of the researchers in the 
field used random permutations to allocate the 150 Trichuris-
infected children into 3 groups, which were again randomised 
to the different doses of albendazole. In accordance with the 
ethical directive, 50 children with no worms in their faeces 
were allocated to the placebo treatment group (25 boys and 25 
girls). In effect, this created a negative control group which 
permitted an estimate of the rate (incidence) of infection under 
lm:Z:II 
the prevailing epidemiological conditions. ~
The trial was blinded in several ways. The albendazole and 
placebo tablets were identical in appearance, including the 
single-tablet blister packaging. Sets of three blister packs for 
each coded recipient were prepared in the laboratory. Packs 
were marked for use on days 1, 2 and 3, respectively (Table 1). 
liD 
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Table I. Treatments over 3 days, repeated 4 times at intervals of 4 months 
Treatments Day 1 
Placebo 
Albendazole* 400 mg 
Albendazole* 800 mg 
Albendazole* 1 200 mg 





At the school, neither the person administering the treatment, 
nor the child receiving the tablet, was aware of the dose. Faecal 
samples were coded and microscopists who processed and 
examined the specimens for helminth eggs were not aware 
which treatment group any sample corresponded to. 
Statistical evaluation and faecal sampling 
Samples of faeces were collected just before each treatment and 
within a month afterwards. This ensured that eggs from re-
infection did not influence the cure rate because it takes more 
than 2 months for eggs from a new Trichuris infection to appear 
in faeces. Cure rates for each dose and treatment occasion were 
analysed by categorical linear modelling for repeated measures 
regression analysis. In addition, the Jonckheere-Terpstra test 
was used to test the hypothesis of a dose effect, versus the null-
hypothesis of no effect, in terms of the geometric mean egg 
count on each occasion. Egg reduction in faeces after 
treatments did not require statistical evaluation because the 







No adverse drug-related effects were reported or detected in 
any treatment group. The only protocol deviation was failure 
to maintain group sizes (Table II). This happened because some 
children inevitably moved to other schools at the end of the 
school year, before the study had been completed. To avoid this 
problem, school-based studies should start and finish within a 
school year whenever possible. 
Statistical power remained adequate because cure rates 
generally exceeded those used in the power calculations (Table 
III). Analysis showed that there was no imbalance between the 
initial geometric mean Trichuris egg counts of the groups for 
treatment with albendazole (Table II). Before treatments 
commenced, infestation by Ascaris was present in 47%,50%, 
54% and 0% of the groups treated with 400, 800, or 1 200 mg of 
albendazole, or placebo, respectively. Ascaris was eliminated by 
the first treatment with albendazole, regardless of the dose. No 
eggs of other helminth species were seen in the faecal samples. 
Table II. Initial and final numbers of children and the geometric means and ranges of Trichuris eggs/g of faeces (epg) before treatments with 
albendazole (Zentel) or placebo 









*Repeated 4 times at intervals of 4 months. 
'Since these children were not infected by worms at the start, the group was a negative control. 





Table III. Cure rates (%)at each treatment with albendazole (Zentel) after initial prevalence of 100% 
Dose Prevalence N After 1 Rx After 2 Rx 
400mg 100 31' 25.8 25.8 
800mg* 100 43' 46.2t 46.51 
1200 mg* 100 39' 53.81 53.81 
*Given as 400 mg on successive days. 
'Number of children who completed 4 treatments. 
Means and ranges (epg) 
961 (323- 11 232)t 
1 015 (321 - 11 387)t 
973 (360- 18 514)t 
0 




1Cure rates for the 800 and 1 200 mg doses were similar and were significantly different from that for the 400 mg dose by categorical linear modelling for repeated 
measures regression analysis (p ~ 0.001). 
Rx ~ treatment 
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Table IV. Geometric means of Trichuris eggs/g of faeces during a series of 4 treatments with albendazole (Zentel) at 3 doses, or with placebo 





31' 961 35.9 16.5 36.1 30.7 
43' 1 015 12 4.5 11.8 6.5 
29' 973 6 4 3.6 2.8 
32' 0 1.4 1.1 2.1 1.7 
*Given as 400 mg on successive days. 
'Since these children were not infected with worms at the start, the group was a negative control. 
1Number of children who completed 4 treatments. 
Rx ~ treatment. 
Table V. Egg-reduction rates (%) during a series of 4 treatments with 3 doses of albendazole (Zentel), relative to Trichuris egg counts before 
treatments commenced 







*Given as 400 mg on successive days. 
!Number of children who completed 4 treatments. 
Rx ~ treatment. 




The results supported the hypothesis in that the 400 mg dose of 
albendazole had an inferior cure rate (range 16.1 - 25.8%), even 
when repeated regularly at intervals of approximately 4 
months. The data are summarised in Table III. On all the 
treatment occasions, the cure rates for the 800 and 1 200 mg 
doses were not significantly different but were better than 
those for the 400 mg dose (p = 0.001). The repeated treatments 
did not increase cure rates significantly after the initial 
differential effect of each dose. The Jonckheere-Terpstra test 
confirmed the dose-related cure rates (data not shown). The 
cure rate for the 400 mg dose was less than the 44% median 
value detected by meta-analysis of 17 trials in tropical 
environments.15 
Trichuris egg-reduction rate 
All the doses of albendazole had strong effects in terms of 
reducing the number of eggs returned to the environment 
(Tables IV and V). The geometric mean egg numbers/g of 
faeces before and after 4 treatments were 961 v. 30.7 (400 mg 
dose), 1 015 v. 6.5 (800 mg dose) and 973 v. 2.8 (1 200 mg dose). 
The final egg-reduction rates relative to the number of eggs/g 
of faeces before the treatments, were 96.8% (400 mg dose), 
99.3% (800 mg dose) and 99.7% (1 200 mg dose). The egg-
reduction rates for all the doses were excellent in relation to the 
minimal acceptable efficacy of 50%, as recommended by the 
World Health Organization (WH0).16 
Rate of infection in the placebo group 
The incidence of infection per annum was 15% for Trichuris and 













29% for Ascaris, under the conditions of the study. This does 
not conflict with the higher prevalence of the former because 
Trichuris adults live for about 3 years in the host, whereas the 
lifespan of Ascaris is only about a year. These infection 
dynamics confirm that the rural environment in which the 
children lived was polluted by human faeces. 
Discussion 
A Cochrane review has reported on meta-analysis of 
deworming trials.17 Results indicated that a single deworming 
treatment with any anthelmintic had a positive effect on 
growth. Based on the models used, the mean gain was either 
0.24 kg or 0.38 kg. Across millions of children, this degree of 
improved growth after 1 treatment would be an enormous 
benefit, even before adding the probable cumulative effect of 
regular treatment starting at 1 or 2 years of age.13 Anaemia in 
women and children en masse also responds positively to 
regular anthelmintic treatment/·7 and serious complications of 
helminthiasis can be prevented in children and adults.'-4 All 
these potential benefits, as well as others related to education, 
would be additive and cost-effective!·' In terms of public and 
child health, the positive effects of helminth control should 
outweigh some possible immune-mediated adverse 
interactions with other conditions, which mainly affect 
individuals, such as atopy.18•19 
If long-term challenge from helminthic antigens can be 
minimised, there may be beneficial effects on HIV I AIDS and 
tuberculosis in terms of infection dynamics, disease 
progression and immunisation!-18-22 Discordant immune 
responses owing to immunological challenge from worms have 
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been shown to impair the effectiveness of some existing 
vaccines.18•19•22 Potential anti-HIV vaccines that are intended to 
function via a cellular immune response may be particularly 
vulnerable." Sustained, synchronised deworming, especially of 
children, may be an economical, short-term way to minimise 
impairment of vaccine trials and effective immunisation. 
Albendazole is a benzimidazole anthelmintic that is on the 
essential drug lists of South Africa and the WH0.14 In South 
Africa, the albendazole doses that have been authorised for 
children include 400 mg stat and 400 mg repeated daily for up 
to 3 days. 14 The present randomised controlled trial tested the 
efficacy of the permitted doses in the winter rainfall area of the 
south-western Cape. The results have pharmacolegal, 
financial, managerial and epidemiological implications. 
Repeating treatment on successive days would increase costs, 
decrease compliance and complicate management. All the 
doses had powerful effects on egg output, making it likely that 
even at the 400 mg dose the cycle of re-infection could be 
broken by sustained, regular treatment for a few years. 
Furthermore, all the treatments were completely effective 
against Ascaris, which regularly causes acute medical 
emergencies that sometimes require surgery.'·'_. 
Current South African legislation categorises albendazole as 
a Schedule 4 medicine.14 This means that a prescription from a 
medical doctor (or a clinical nurse practitioner) is needed in 
order to dispense the drug and treat a specific patient. Without 
such authorisation, treatment by a nurse, paramedic, 
pharmacist, parent, teacher, health care worker or lay person 
contravenes the schedule. It follows that the schedule 4 status 
is not compatible with the use of albendazole in school-based, 
non-selective deworming programmes. However, albendazole 
has an excellent global safety record and is highly effective 
against hookworm, which is endemic in parts of KwaZulu-
Natal, Mozambique and Zimbabwe.2•11 ~13 These helminths are 
one cause of anaemia because they feed on blood obtained by 
lacerating the intestinal wall and releasing anticoagulant. It is 
clear that albendazole should not be in a prescription niche that 
puts it out of reach of children and women living in poverty, 
but which might increase profit. Neither will the Schedule 4 
rating serve to keep albendazole in reserve in case resistance 
develops to mebendazole (Schedule 1), because of cross-
resistance between benzimidazoles. South Africa should 
conform to practice in other countries by de-scheduling 
albendazole as a matter of urgency in order to permit 
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unrestricted use in deworming programmes, especially where 
hookworm is endemic.11 •12 
The Peninsula School Feeding Association funded part of the 
cost of the randomised controlled trial and GlaxoSmithKline 
donated the albendazole and placebo tablets. Anglo American 
Chairman's Fund, AngloGold Fund, De Beers Fund and AusAID 
have supported operational and developmental research to 
implement creche- and school-based deworming, health education 
and sanitation in impoverished communities in the south-western 
Cape. 
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